More Business Wire
View Older Stories View Newer Stories-
Super Group Reports Financial Results for Fourth Quarter 2023 and Full Year 2023
-
ITB Berlin 2024: Cairo City Break to Become a New Egypt Travel Trend
-
EVERTEC Enters Into Accelerated Share Repurchase Agreement
-
Agenus Announces Preclinical Data on BMS-986442 (AGEN1777) at AACR 2024
-
Zai Lab Announces Participation in March Investor Conference
-
National Vision Holdings, Inc. Announces Participation in the UBS Global Consumer and Retail Conference
-
Campbell Reports Second-Quarter Fiscal 2024 Results
-
United Natural Foods Names Giorgio Matteo Tarditi President and Chief Financial Officer
-
Idea Decanter Announces Strategic Partnership with FMG
-
Xeris Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Events
-
Tango Therapeutics to Participate in Upcoming Investor Conferences
-
EVgo Inc. Reports Fourth Quarter and Full Year 2023 Results
-
Sweet Security Raises $33 Million Series A, Upgrades Its Runtime Security Suite to Usher in a New Era for Cloud Security
-
Scribe Therapeutics to Participate in the Leerink Partners Global Biopharma Conference
-
Quantum Energy Corporation Completes First Quantum Licensed Distributor Agreement
-
KORU Medical Systems Signs a Clinical Supply Agreement for Phase 3 Trial with Leading Pharma Partner Using Custom Device for a Novel Subcutaneous Immunoglobulin
-
D-Wave Quantum Inc. to Participate in 36th Annual Roth Conference
-
STAAR Surgical to Participate in Two Upcoming Investor Conferences
-
Itron to Host Investor Day at Nasdaq MarketSite
-
Rockwell Automation to Present at BofA Global Industrials Conference
-
Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy
-
Xeris Refinances Its $150M Senior Secured Term Loan Facility With Hayfin Capital
-
Genius Sports Reports Fourth Quarter and Full-Year Results Above Expectations and Announces 2024 Outlook for Group Revenue Growth and Adj. EBITDA Margin Expansion
-
REV Group, Inc. Reports Strong First Quarter Results, Provides Updated Fiscal 2024 Outlook
-
Fierce Medtech Names Genesis Therapeutics a “Fierce 15” Company of 2023
-
Vedanta Biosciences to Host Investor Meetings at the Leerink Partners 2024 Global Biopharma Conference
-
Meketa Investment Group Expands Employee Ownership Team
-
Checkmarx and Security Compass Announce Partnership to Integrate Checkmarx One with SD Elements
-
Laser Photonics Joins Brokk at Waste Management Symposia 2024
-
VedaBio Strengthens Management Team
-
Dalet and Veritone Reach Agreement to Distribute, Transact and Monetize Media Archives
-
C₂N Diagnostics, LLC Announces Investment From Eisai Inc.
-
Enanta Pharmaceuticals to Participate at Leerink Partners Global Biopharma Conference
-
Port Authority NY NJ Expands use of KEMS After Life Saving Event
-
Global Technology Leader Sameer Gaikwad Named Vice President of Account Management and Customer Success at VirtualHealth
-
Army Selects Palantir to Deliver TITAN Next Generation Deep-Sensing Capability in Prototype Maturation Phase
-
Palantir to Unveil New Customers at Oversubscribed AIPCon
-
United Natural Foods, Inc. Reports Second Quarter Fiscal 2024 Results
-
Pentair Hosts 2024 Investor Day
-
NeueHealth Reports Fourth Quarter and Full Year 2023 Results
-
Korn Ferry Announces Third Quarter Fiscal 2024 Results of Operations
-
J.Jill, Inc. to Report Fourth Quarter and Fiscal Year 2023 Results on March 20, 2024
-
Ferguson Share Repurchase Program - Weekly Report
-
Air Liquide: Voting Rights
-
KalVista Pharmaceuticals to Participate in the Leerink Partners 2024 Global Biopharma Conference
-
Cazoo Announces Transition to Pure-Play Automotive Marketplace Business Model
-
Terran Orbital Awarded Up To $45 Million IDIQ by NASA to Support Space Technology Advancement
-
ITT Announces Participation at Bank of America Global Industrials Conference 2024 on March 19
-
GE Vernova Hosts 2024 Investor Day
-
ATREG Announces Completion of Nexperia’s Newport, UK Fab Sale to Vishay
